In the present study, IL-17 was more sensitive than GM for the diagnosis of IPA in non-neutropenic patients, both in plasma and BALF, Combined diagnostic testing of GM and IL-17 may improve the diagnostic efficiency of IPA in non-neutropenic patients. Here, IL17A is linked to Ito hypomelanosis.